Gemelli Biotech Corp. — Form D

Gemelli Biotech Corp. of Raleigh, NC, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-28. The offering totals $3.0M, of which $1.9M was reported sold. Industry: Biotechnology.

Offering

Filed: 2019-06-28
Form: D
Accession: 0001780605-19-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $3.0M
Amount sold: $1.9M
Remaining: $1.1M
Investors: 13
Date of first sale: 2019-06-14
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-343040

Issuer

Name: Gemelli Biotech Corp.
CIK: 0001780605
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2018
Address: 2009 Fairview Rd. #6099, Raleigh, NC, 27628
Phone: (919) 451-0533

Officers, directors & promoters (8)

Name	Role	Location
John A Neczesny	Director	Raleigh, NC
Matthew Mitcho	Director	Raleigh, NC
Matthew Mitcho	Executive Officer	Raleigh, NC
Oded A Levy	Director	Raleigh, NC
Ritish A Agarwal	Director	Raleigh, NC
James Laur	Director	Raleigh, NC
Mark Pimentel	Director	Raleigh, NC
Mark Pimentel	Executive Officer	Raleigh, NC

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2024-12-02	D/A	$23.9M	$21.2M
2022-06-08	D	$20.0M	$18.9M
2021-03-29	D/A	$5.5M	$5.5M
2021-03-26	D	$5.0M	$5.0M

More